Our Research

Our research

Over the past 20 years we have carried out a range of clinical studies on stem cell care.

Published papers

10

+

International journal indexing

SCIE / SCOPUS

Original paper: [Myocardial Infarction Phase 3] Safety and Effects on Cardiac Function of Coronary Artery Injection of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Patients with Acute Myocardial Infarction (SEED-MSC Study)

Heart

[Myocardial Infarction Phase 3] Safety and Effects on Cardiac Function of Coronary Artery Injection of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Patients with Acute Myocardial Infarction (SEED-MSC Study)

Jun-Won Lee, Seung-Hwan Lee, et al.

View details

Original paper: [Postmarketing Study] Safety and Effects on Left Ventricular Function of Coronary Artery Injection of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Patients with Anterior Wall Acute Myocardial Infarction

Heart

[Postmarketing Study] Safety and Effects on Left Ventricular Function of Coronary Artery Injection of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Patients with Anterior Wall Acute Myocardial Infarction

HYUNSOO KIM, Su Hyun Kim et al.

View details

Original paper: [Spinal Cord Injury Phase 1] Long-term Follow-up Results of Intraspinal Administration of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Patients with Spinal Cord Injury

Neurology

[Spinal Cord Injury Phase 1] Long-term Follow-up Results of Intraspinal Administration of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Patients with Spinal Cord Injury

Jin Hoon Park, Sang Ryong Jeon et al.

View details

Original paper: [Phase 1 Study on Spinal Cord Injury] Safety and Changes in Motor Function Following Administration of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Patients with Spinal Cord Injury

Nerve

[Phase 1 Study on Spinal Cord Injury] Safety and Changes in Motor Function Following Administration of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Patients with Spinal Cord Injury

HYUNSOO KIM, Sang Ryong Jeon et al.

View details

Original paper: [Stroke Phase 3] Five-Year Safety and Functional Outcomes of Intravenous Administration of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Patients with Ischemic Stroke (STARTING Study)

Nerve

[Stroke Phase 3] Five-Year Safety and Functional Outcomes of Intravenous Administration of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Patients with Ischemic Stroke (STARTING Study)

Jin Soo Lee, Oh Young Bang, et al.

View details

Original paper: [Phase 1/2 Stroke Trial] Safety and Functional Recovery Following Intravenous Administration of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Patients with Ischemic Stroke

Nerve

[Phase 1/2 Stroke Trial] Safety and Functional Recovery Following Intravenous Administration of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Patients with Ischemic Stroke

Oh Young Bang, Jin Soo Lee, et al.

View details

Original paper: [Stage 2 Cirrhosis] Changes in Liver Fibrosis Following Hepatic Artery Injection of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Patients with Alcoholic Cirrhosis

Liver

[Stage 2 Cirrhosis] Changes in Liver Fibrosis Following Hepatic Artery Injection of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Patients with Alcoholic Cirrhosis

HYUNSOO KIM, Yoon Ok Jang, et al.

View details

Original paper: [Stage 2 Cirrhosis] Safety and Efficacy of Hepatic Artery Injection of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Patients with Alcoholic Cirrhosis (Phase 2 Clinical Trial)

Liver

[Stage 2 Cirrhosis] Safety and Efficacy of Hepatic Artery Injection of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Patients with Alcoholic Cirrhosis (Phase 2 Clinical Trial)

Ki Tae Suk, Soon Koo Baik, et al.

View details

Original paper: [Parkinson's] Safety and Delay of Disease Progression Following Administration of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Patients with Multiple System Atrophy

Nerve

[Parkinson's] Safety and Delay of Disease Progression Following Administration of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Patients with Multiple System Atrophy

PH Lee, JW Kim et al.

View details